R
Ronnie H. Fang
Researcher at University of California, San Diego
Publications - 145
Citations - 16826
Ronnie H. Fang is an academic researcher from University of California, San Diego. The author has contributed to research in topics: Medicine & Nanoparticle. The author has an hindex of 53, co-authored 117 publications receiving 10854 citations. Previous affiliations of Ronnie H. Fang include University of Montana & University of California.
Papers
More filters
Journal ArticleDOI
Erythrocyte membrane-camouflaged polymeric nanoparticles as a biomimetic delivery platform
TL;DR: A top-down biomimetic approach in particle functionalization is reported by coating biodegradable polymeric nanoparticles with natural erythrocyte membranes, including both membrane lipids and associated membrane proteins for long-circulating cargo delivery.
Journal ArticleDOI
Nanoparticle biointerfacing by platelet membrane cloaking
Che Ming Jack Hu,Ronnie H. Fang,Kuei Chun Wang,Brian T. Luk,Soracha Thamphiwatana,Diana Dehaini,Phu Nguyen,Pavimol Angsantikul,Cindy Wen,Ashley V. Kroll,Cody W. Carpenter,Manikantan Ramesh,Vivian Qu,Sherrina Patel,Jie Zhu,William Shi,Florence M. Hofman,Thomas C. Chen,Weiwei Gao,Kang Zhang,Shu Chien,Liangfang Zhang +21 more
TL;DR: The multifaceted biointerfacing enabled by the platelet membrane cloaking method provides a new approach in developing functional nanoparticles for disease-targeted delivery.
Journal ArticleDOI
Cancer Cell Membrane-Coated Nanoparticles for Anticancer Vaccination and Drug Delivery
Ronnie H. Fang,Che Ming Jack Hu,Brian T. Luk,Weiwei Gao,Jonathan Copp,Yiyin Tai,Derek E. O'Connor,Liangfang Zhang +7 more
TL;DR: The biological functionalization of polymeric nanoparticles with a layer of membrane coating derived from cancer cells is reported on, showing that by coupling the particles with an immunological adjuvant, the resulting formulation can be used to promote a tumor-specific immune response for use in vaccine applications.
Journal ArticleDOI
Cell Membrane Coating Nanotechnology
TL;DR: There is still significant room for development, as researchers continue to refine existing workflows while finding new and exciting applications that can take advantage of this developing technology, cell‐membrane‐coating nanotechnology.
Journal ArticleDOI
A biomimetic nanosponge that absorbs pore-forming toxins.
TL;DR: The nanosponge, which consists of a polymeric nanoparticle core surrounded by red blood cell membranes, absorbs membrane-damaging toxins and diverts them away from their cellular targets and markedly reduce the toxicity of staphylococcal alpha-hemolysin and thus improve the survival rate of toxin-challenged mice.